Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 876 record(s)

Req # A-2019-001891

Adverse Reaction Report (AER). Report number: E2B_02804833.

Organization: Health Canada

22 page(s)
March 2020

Req # A-2019-001911

Adverse Reaction Report (AER). Report number: E2B_02777113.

Organization: Health Canada

144 page(s)
March 2020

Req # A-2019-001912

Adverse Reaction Report (AER). Report number: E2B_02807309.

Organization: Health Canada

28 page(s)
March 2020

Req # A-2019-001922

Adverse Reaction Report (AER) for Guanfacine. Report number: E2B_02774351.

Organization: Health Canada

8 page(s)
March 2020

Req # A-2019-001958

Adverse Reaction Report (AER). Report numbers: E2B_02777617, E2B_02779836.

Organization: Health Canada

12 page(s)
March 2020

Req # A-2016-000926

All records describing substantive changes to the organizational structure of the Healthy Environments and Consumer Safety Branch for the period July 27, 2016 to October 25, 2016.

Organization: Health Canada

185 page(s)
February 2020

Req # A-2019-001273

All briefing documents on prescription drug insurance that were prepared for the new Minister from July 1 to October 31, 2019.

Organization: Health Canada

16 page(s)
February 2020

Req # A-2019-001509

Industrial Hemp Application Guide, Industrial Hemp Regulations, Regulatory Impact Analysis Statement, Canadian Hemp Trade Alliance (CHTA) presentations, Industrial Hemp: Cannabis Tracking and Licensing System User Guide.

Organization: Health Canada

835 page(s)
February 2020

Req # A-2019-001511

Good Production Practices (GPP) Guidance, Analytical Testing Application Guide, as well as response to correspondence received from an external individual on methodology for laboratory testing for cannabis including second wave products.

Organization: Health Canada

120 page(s)
February 2020

Req # A-2019-001514

The policy for the Inclusion of Cannabis Varieties on the List of Approved Cultivars and List of Approved Cultivars for the 2019 Growing Season.

Organization: Health Canada

11 page(s)
February 2020
Date modified: